A clinical trial aiming to compare energy ramping and fixed-dose protocols in Extracorporeal Shock Wave Lithotripsy (ESWL) for kidney stone treatment has been announced. The study, sponsored by Mohammed Abdelhafez, is not yet actively recruiting participants, according to a record updated on January 13, 2026. It is anticipated to provide significant insights for clinicians, medical device professionals, and regulatory teams.
Extracorporeal Shock Wave Lithotripsy (ESWL) is a non-invasive procedure widely used for disintegrating renal calculi. By contrasting these two dosing regimens, the trial expects to yield crucial data on the procedure’s performance, safety, and patient outcomes.
In this article:
- What is the aim of the trial?
- Who should care about this research?
- What are the larger implications?
- FAQs
- Takeaways
- Disclaimer
What is the aim of the trial?
Recently posted under ClinicalTrials.gov (Identifier: NCT07334236), the study will explore whether different energy application techniques in ESWL offer better outcomes in treating renal calculi. The study details that one group of patients will receive energy ramping (gradual increase in shock wave intensity), while another will undergo a fixed-dose approach throughout the procedure.
Energy ramping in ESWL is hypothesized to acclimate tissues gradually to rising energy levels, potentially resulting in reduced complications. Fixed-dose ESWL, on the other hand, applies a consistent intensity throughout the session.
Who should care about this research?
This trial holds significance for:
- Medical device manufacturers specializing in lithotripsy equipment by providing insights to refine device protocols.
- Regulatory professionals overseeing approvals and compliance for medical devices targeting stone disease treatment.
- Healthcare practitioners in urology and nephrology seeking evidence-backed guidance on treatment plans.
Understanding energy application techniques may influence standard operating practices for clinics conducting ESWL.
What are the larger implications?
The findings of this trial could help set benchmarks for the optimal balance between efficacy and patient safety in ESWL procedures. Regulatory reviewers could use these results to scrutinize labeling claims or indications for use in similar devices.
From a healthcare perspective, the comparison between energy ramping and constant-dose shock waves may inform device-specific training and enhance clinical outcomes, thus improving health economics in minimally invasive kidney stone management.
FAQs
- What is the focus of this trial?
It compares energy ramping and fixed-dose protocols in ESWL for treating kidney stones.
- Is the study recruiting participants?
No, it is listed as not yet recruiting participants on ClinicalTrials.gov as of January 2026.
- Who is sponsoring the research?
The study is sponsored by Mohammed Abdelhafez.
- How can I access the trial details?
Details are available on the ClinicalTrials.gov website under Identifier NCT07334236.
Takeaways
The study addressing energy ramping versus fixed-dose ESWL could have far-reaching implications for clinical practice, device development, and medical regulations. Stakeholders are encouraged to monitor updates as the trial progresses and begins recruitment. With its potential to improve safety and efficacy, this research represents a valuable opportunity to refine extracorporeal lithotripsy protocols.
Disclaimer
This article is for informational purposes only and does not constitute legal or clinical advice. Professionals should refer to official trial listings and guidelines.
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07334236?term=medical+device